PreprintCited by 25Alzheimer's disease research and treatmentsMitochondrial Function and PathologyDementia and Cognitive Impairment Research

Role of RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease

Open access
Awasthi, Sanjay, Hindle, Ashley, Sawant, Neha A., George, Mathew, Vijayan, Murali, Kshirsagar, Sudhir, Morton, Hallie, Bunquin, Lloyd E. +6 more·2021·Cells

Preprint — published as 10.3390/cells10113113

Abstract

The purpose of our study is to understand the role of the Ralbp1 gene in oxidative stress (OS), mitochondrial dysfunction and cognition in Alzheimer’s disease (AD) pathogenesis. The Ralbp1 gene encodes the 76 kDa protein Rlip ( aka RLIP76). Previous studies have revealed its role in OS-related cancer. However, Rlip is transcriptionally regulated by EP300 , a CREB-binding protein that is important for synaptic plasticity in the brain. Rlip functions as a stress-responsive/protective transporter of glutathione conjugates (GS-E) and xenobiotic toxins. OS causes rapid cellular accumulation of Rlip and its translocation from a tubulin-bound complex to the plasma membrane, mitochondria and nucleus. Therefore, Rlip may play an important role in maintaining cognitive function in the face of OS-related injury. This study is aimed to determine whether Rlip deficiency in mice is associated with AD-like cognitive and mitochondrial dysfunction. Brain tissue obtained from cohorts of wildtype and Rlip +/- mice were analyzed for OS markers, expression of genes that regulate mitochondrial fission/fusion, and synaptic integrity. We also examined mitochondrial ultrastructure in mouse brains obtained from these mice and further analyzed the impact of Rlip deficiency on gene networks of AD, aging, inhibition of stress-activated gene expression, mitochondrial function, and CREB signaling. Our studies revealed a significant increase in the levels of OS markers and alterations in the expression of genes and proteins involved in mitochondrial biogenesis, dynamics and synapses in brain tissues of these mice. Furthermore, we compared the cognitive function of wildtype and Rlip +/- mice. Behavioral, basic motor and sensory function tests in Rlip +/- mice revealed cognitive decline, similar to AD. Gene network analysis indicated dysregulation of stress-activated gene expression, mitochondrial function, and CREB signaling genes in the Rlip +/- mouse liver. Our results suggest that the Rlip deficiency-associated increase in OS and mitochondrial dysfunction could contribute to the development of OS-related AD processes. Therefore, the restoration of Rlip activity and endogenous cytoprotective mechanisms by pharmacological interventions is a novel approach to protect against AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2021.09.20.461132

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Rlip+/− mice show cognitive impairments, increased oxidative stress, and mitochondrial abnormalities, features similar to late-onset AD.

    “Recently, we reported that mice with a heterozygous loss of Rlip (Rlip+/−) showed cognitive impairments, increased oxidative stress, and mitochondrial abnormalities, features similar to those seen in late-onset AD [14].”

    From Rlip76: An Unexplored Player in Neurodegeneration and Alzheimer’s Disease? (2022) · cites this paper as [14]

    The Discussion (section 4, page not available) reports cognitive deficits, reduced antioxidant-enzyme activity, and altered mitochondrial dynamics in Rlip+/− mice, and compares these features with AD mouse models. The Introduction distinguishes late-onset sporadic AD from early-onset familial AD, but the paper does not specifically establish that the mice’s features resemble late-onset AD rather than AD more generally. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Glutathione peroxidase activity decreased in Rlip+/− mice, indicating loss of mitochondrial function.

    “Consistently, the activity of glutathione peroxidase, a mitochondrial antioxidant enzyme, decreased in the Rlip+/− mice, which also indicates a loss of mitochondrial function [14].”

    From Rlip76: An Unexplored Player in Neurodegeneration and Alzheimer’s Disease? (2022) · cites this paper as [14]

    The Discussion reports significantly reduced glutathione peroxidase activity in Rlip+/− mice compared with age-matched wildtype mice, alongside mitochondrial abnormalities. But the assay measured activity in brain homogenates (Methods, §2.8), and the paper does not establish that the decrease itself indicates a loss of mitochondrial function. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • Rlip+/− mice have significant increases in dentate gyrus and hippocampus expression of Drp1 and Fis1, and decreased expression of MFN1.

    “Our recent findings show that heterozygous Rlip KO (Rlip+/−) mice have significant increases in the dentate gyrus and hippocampus expression of Drp1 and Fis1, genes involved with mitochondrial fission, and decreased expression of the mitofusin MFN1 [14].”

    From Rlip76: An Unexplored Player in Neurodegeneration and Alzheimer’s Disease? (2022) · cites this paper as [14]

    Section 3.4.1 (p. 16) reports significantly increased hippocampal Drp1 and Fis1 immunoreactivity and significantly reduced Mfn1 in Rlip+/− mice relative to wild-type mice. The copy does not identify a separate dentate gyrus result, so that more specific location is not established. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • Rlip+/− mice have significant reductions of synaptophysin and PSD95 in brains relative to WT, likely indicating poor synaptic health.

    “We recently examined the synaptic proteins synaptophysin and PSD95 and found significant reductions of both proteins in the brains of Rlip+/− mice relative to WT mice, likely indicating poor synaptic health [14].”

    From Rlip76: An Unexplored Player in Neurodegeneration and Alzheimer’s Disease? (2022) · cites this paper as [14]

    Section 3.2.3 reports significant reductions in synaptophysin and PSD95 mRNA transcripts in Rlip+/− mice. Section 4.2 links reduced synaptic-gene expression to possible synaptic damage and impaired synaptic health. The passages do not establish significant reductions in the two proteins themselves, as the citing sentence says. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • In brains of Rlip+/− mice, increased expression of NRF2 was found.

    “Consistent with elevated ROS, in the brains of Rlip+/− mice we found increased expression of NRF2 [14], a master transcription factor which is activated by oxidative stress and which subsequently induces the cell’s antioxidant system.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 82

  1. Knopman, D.S.; DeKosky, S.T.; Cummings, J.L.; Chui, H.; Corey-Bloom, J.; Relkin, N.; Small, G.W.; Miller, B.; Stevens, J.C. Practice parameter: Diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001, 56, 1143-1153. [CrossRef] [PubMed] · DOI · Paper page
  2. Alzheimer's Association Report. 2020 Alzheimer's disease facts and figures. Alzheimer's Dement. 2020, 16, 319-460. [CrossRef] · DOI · Paper page
  3. Colnaghi, L.; Rondelli, D.; Muzi-Falconi, M.; Sertic, S. Tau and DNA Damage in Neurodegeneration. Brain Sci. 2020, 10, 946. [CrossRef] · DOI
  4. Iqbal, K.; Liu, F.; Gong, C.X.; Grundke-Iqbal, I. Tau in Alzheimer disease and related tauopathies. Curr. Alzheimer Res. 2010, 7, 656-664. [CrossRef] [PubMed] · DOI
  5. Mormino, E.C.; Betensky, R.A.; Hedden, T.; Schultz, A.P.; Amariglio, R.E.; Rentz, D.M.; Johnson, K.A.; Sperling, R.A. Synergistic effect of β-amyloid and neurodegeneration on cognitive decline in clinically normal individuals. JAMA Neurol. 2014, 71, 1379-1385. [CrossRef] [PubMed] · DOI · Paper page
  6. Landau, S.M.; Harvey, D.; Madison, C.M.; Koeppe, R.A.; Reiman, E.M.; Foster, N.L.; Weiner, M.W.; Jagust, W.J. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol. Aging 2011, 32, 1207-1218. [CrossRef] · DOI · Paper page
  7. Olivito, G.; Serra, L.; Marra, C.; Di Domenico, C.; Caltagirone, C.; Toniolo, S.; Cercignani, M.; Leggio, M.; Bozzali, M. Cerebellar dentate nucleus functional connectivity with cerebral cortex in Alzheimer's disease and memory: A seed-based approach. Neurobiol. Aging 2020, 89, 32-40. [CrossRef] [PubMed] · DOI
  8. Tao, W.-Y.; Yu, L.-J.; Jiang, S.; Cao, X.; Chen, J.; Bao, X.-Y.; Li, F.; Xu, Y.; Zhu, X.-L. Neuroprotective effects of ZL006 in Aβ1-42-treated neuronal cells. Neural Regen. Res. 2020, 15, 2296-2305. [CrossRef] · DOI
  9. Stamer, K.; Vogel, R.; Thies, E.; Mandelkow, E.; Mandelkow, E.M. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol. 2002, 156, 1051-1063. [CrossRef] [PubMed] · DOI · Paper page
  10. Pradeepkiran, J.A.; Reddy, P.H. Defective mitophagy in Alzheimer's disease. Ageing Res. Rev. 2020, 64, 101191. [CrossRef] · DOI · Paper page
  11. Jangampalli Adi, P.; Reddy, P.H. Phosphorylated tau targeted small-molecule PROTACs for the treatment of Alzheimer's disease and tauopathies. Biochim. Biophys. Acta Mol. Basis Dis. 2021, 1867, 166162. [CrossRef] · DOI
  12. Kumar, S.; Reddy, P.H. Elevated levels of MicroRNA-455-3p in the cerebrospinal fluid of Alzheimer's patients: A potential biomarker for Alzheimer's disease. Biochim. Biophys. Acta Mol. Basis Dis. 2021, 1867, 166052. [CrossRef] [PubMed] · DOI
  13. Kumar, S.; Reddy, P.H. The role of synaptic microRNAs in Alzheimer's disease. Biochim. Biophys. Acta Mol. Basis Dis. 2020, 1866, 165937. [CrossRef] · DOI
  14. Smith, M.A.; Zhu, X.; Tabaton, M.; Liu, G.; McKeel, D.W., Jr.; Cohen, M.L.; Wang, X.; Siedlak, S.L.; Dwyer, B.E.; Hayashi, T.; et al. Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J. Alzheimers Dis. 2010, 19, 363-372. [CrossRef] [PubMed] · DOI
  15. Bonda, D.J.; Wang, X.; Perry, G.; Nunomura, A.; Tabaton, M.; Zhu, X.; Smith, M.A. Oxidative stress in Alzheimer disease: A possibility for prevention. Neuropharmacology 2010, 59, 290-294. [CrossRef] · DOI
  16. Beal, M.F. Mitochondria take center stage in aging and neurodegeneration. Ann. Neurol. 2005, 58, 495-505. [CrossRef] · DOI · Paper page
  17. Reddy, P.H.; Beal, M.F. Amyloid beta, mitochondrial dysfunction and synaptic damage: Implications for cognitive decline in aging and Alzheimer's disease. Trends Mol. Med. 2008, 14, 45-53. [CrossRef] [PubMed] · DOI · Paper page
  18. Reddy, P.H. Mitochondrial medicine for aging and neurodegenerative diseases. Neuromol. Med. 2008, 10, 291-315. [CrossRef] [PubMed] · DOI · Paper page
  19. Reddy, P.H. Amyloid precursor protein-mediated free radicals and oxidative damage: Implications for the development and progression of Alzheimer's disease. J. Neurochem. 2006, 96, 1-13. [CrossRef] [PubMed] · DOI
  20. Kim, G.H.; Kim, J.E.; Rhie, S.J.; Yoon, S. The Role of Oxidative Stress in Neurodegenerative Diseases. Exp. Neurobiol. 2015, 24, 325-340. [CrossRef] · DOI · Paper page
  21. Gil-Mohapel, J.; Brocardo, P.S.; Christie, B.R. The role of oxidative stress in Huntington's disease: Are antioxidants good therapeutic candidates? Curr. Drug Targets 2014, 15, 454-468. [CrossRef] · DOI · Paper page
  22. Aguiar, C.C.; Almeida, A.B.; Araujo, P.V.; de Abreu, R.N.; Chaves, E.M.; do Vale, O.C.; Macedo, D.S.; Woods, D.J.; Fonteles, M.M.; Vasconcelos, S.M. Oxidative stress and epilepsy: Literature review. Oxid. Med. Cell. Longev. 2012, 2012, 795259. [CrossRef] [PubMed] · DOI
  23. Gella, A.; Durany, N. Oxidative stress in Alzheimer disease. Cell Adhes. Migr. 2009, 3, 88-93. [CrossRef] [PubMed] · DOI · Paper page
  24. Lovell, M.A.; Markesbery, W.R. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease. Nucleic Acids Res. 2007, 35, 7497-7504. [CrossRef] [PubMed] · DOI · Paper page
  25. Siegel, S.J.; Bieschke, J.; Powers, E.T.; Kelly, J.W. The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofibril formation. Biochemistry 2007, 46, 1503-1510. [CrossRef] · DOI
  26. Sultana, R.; Perluigi, M.; Butterfield, D.A. Lipid peroxidation triggers neurodegeneration: A redox proteomics view into the Alzheimer disease brain. Free Radic. Biol. Med. 2013, 62, 157-169. [CrossRef] [PubMed] · DOI · Paper page
  27. Hinchman, C.A.; Ballatori, N. Glutathione conjugation and conversion to mercapturic acids can occur as an intrahepatic process. J. Toxicol. Environ. Health 1994, 41, 387-409. [CrossRef] [PubMed] · DOI
  28. Habig, W.H.; Pabst, M.J.; Jakoby, W.B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974, 249, 7130-7139. [CrossRef] · DOI
  29. Tonelli, C.; Chio, I.I.C.; Tuveson, D.A. Transcriptional Regulation by Nrf2. Antioxid. Redox Signal. 2018, 29, 1727-1745. [CrossRef] · DOI
  30. Hayes, J.D.; Flanagan, J.U.; Jowsey, I.R. Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 2005, 45, 51-88. [CrossRef] · DOI
  31. Miller, C.J.; Gounder, S.S.; Kannan, S.; Goutam, K.; Muthusamy, V.R.; Firpo, M.A.; Symons, J.D.; Paine, R., 3rd; Hoidal, J.R.; Rajasekaran, N.S. Disruption of Nrf2/ARE signaling impairs antioxidant mechanisms and promotes cell degradation pathways in aged skeletal muscle. Biochim. Biophys. Acta 2012, 1822, 1038-1050. [CrossRef] [PubMed] · DOI
  32. Ungvari, Z.; Bailey-Downs, L.; Gautam, T.; Sosnowska, D.; Wang, M.; Monticone, R.E.; Telljohann, R.; Pinto, J.T.; de Cabo, R.; Sonntag, W.E.; et al. Age-associated vascular oxidative stress, Nrf2 dysfunction, and NF-{kappa}B activation in the nonhuman primate Macaca mulatta. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 2011, 66, 866-875. [CrossRef] [PubMed] · DOI
  33. Edward, F.; LaBelle, S.V.S.; Hassan Ahmad, L.W.; Yogesh, C.A. A novel dinitrophenylglutathione-stimulated ATPase is present in human erythrocyte membranes. FEBS Lett. 1988, 228, 53-56.
  34. Sharma, R.; Gupta, S.; Singh, S.V.; Medh, R.D.; Ahmad, H.; LaBelle, E.F.; Awasthi, Y.C. Purification and characterization of dinitrophenylglutathione ATPase of human erythrocytes and its expression in other tissues. Biochem. Biophys. Res. Commun. 1990, 171, 155-161. [CrossRef] · DOI
  35. Awasthi, Y.C.; Singhal, S.S.; Gupta, S.; Ahmad, H.; Zimniak, P.; Radominska, A.; Lester, R.; Sharma, R. Purification and characterization of an ATPase from human liver which catalyzes ATP hydrolysis in the presence of the conjugates of bilirubin, bile acids and glutathione. Biochem. Biophys. Res. Commun. 1991, 175, 1090-1096. [CrossRef] · DOI
  36. Singhal, S.S.; Wickramarachchi, D.; Yadav, S.; Singhal, J.; Leake, K.; Vatsyayan, R.; Chaudhary, P.; Lelsani, P.; Suzuki, S.; Yang, S.; et al. Glutathione-conjugate transport by RLIP76 is required for clathrin-dependent endocytosis and chemical carcinogenesis. Mol. Cancer Ther. 2011, 10, 16-28. [CrossRef] · DOI · Paper page
  37. Singhal, S.S.; Salgia, R.; Singhal, S.; Horne, D.; Awasthi, S. RLIP: An existential requirement for breast carcinogenesis. Biochim. Biophys. Acta Rev. Cancer 2019, 1871, 281-288. [CrossRef] · DOI · Paper page
  38. Nakashima, S.; Morinaka, K.; Koyama, S.; Ikeda, M.; Kishida, M.; Okawa, K.; Iwamatsu, A.; Kishida, S.; Kikuchi, A. Small G protein Ral and its downstream molecules regulate endocytosis of EGF and insulin receptors. EMBO J. 1999, 18, 3629-3642. [CrossRef] · DOI · Paper page
  39. Morinaka, K.; Koyama, S.; Nakashima, S.; Hinoi, T.; Okawa, K.; Iwamatsu, A.; Kikuchi, A. Epsin binds to the EH domain of POB1 and regulates receptor-mediated endocytosis. Oncogene 1999, 18, 5915-5922. [CrossRef] · DOI
  40. Bendris, N.; Schmid, S.L. Endocytosis, Metastasis and Beyond: Multiple Facets of SNX9. Trends Cell Biol. 2017, 27, 189-200. [CrossRef] · DOI
  41. Bose, C.; Singh, S.P.; Igid, H.; Green, W.C.; Singhal, S.S.; Lee, J.; Palade, P.T.; Rajan, A.; Ball, S.; Tonk, V.; et al. Topical 2 -Hydroxyflavanone for Cutaneous Melanoma. Cancers 2019, 11, 1556. [CrossRef] [PubMed] · DOI
  42. Awasthi, S.; Tompkins, J.; Singhal, J.; Riggs, A.D.; Yadav, S.; Wu, X.; Singh, S.; Warden, C.; Liu, Z.; Wang, J.; et al. Rlip depletion prevents spontaneous neoplasia in TP53 null mice. Proc. Natl. Acad. Sci. USA 2018, 115, 3918-3923. [CrossRef] [PubMed] Cells 2021, 10, 3113 · DOI · Paper page
  43. Kashatus, D.F.; Lim, K.H.; Brady, D.C.; Pershing, N.L.; Cox, A.D.; Counter, C.M. RALA and RALBP1 regulate mitochondrial fission at mitosis. Nat. Cell Biol. 2011, 13, 1108-1115. [CrossRef] · DOI · Paper page
  44. Awasthi, S.; Singhal, S.S.; Yadav, S.; Singhal, J.; Drake, K.; Nadkar, A.; Zajac, E.; Wickramarachchi, D.; Rowe, N.; Yacoub, A.; et al. RLIP76 is a major determinant of radiation sensitivity. Cancer Res. 2005, 65, 6022-6028. [CrossRef] · DOI · Paper page
  45. Reddy, P.H.; Yin, X.; Manczak, M.; Kumar, S.; Pradeepkiran, J.A.; Vijayan, M.; Reddy, A.P. Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer's disease. Hum. Mol. Genet. 2018, 27, 2502-2516. [CrossRef] [PubMed] · DOI
  46. Pradeepkiran, J.A.; Reddy, A.P.; Yin, X.; Manczak, M.; Reddy, P.H. Protective effects of BACE1 inhibitory ligand molecules against amyloid beta-induced synaptic and mitochondrial toxicities in Alzheimer's disease. Hum. Mol. Genet. 2020, 29, 49-69. [CrossRef] [PubMed] · DOI
  47. Yang, D.; Ying, J.; Wang, X.; Zhao, T.; Yoon, S.; Fang, Y.; Zheng, Q.; Liu, X.; Yu, W.; Hua, F. Mitochondrial Dynamics: A Key Role in Neurodegeneration and a Potential Target for Neurodegenerative Disease. Front. Neurosci. 2021, 15, 654785. [CrossRef] [PubMed] · DOI
  48. Morton, H.; Kshirsagar, S.; Orlov, E.; Bunquin, L.E.; Sawant, N.; Boleng, L.; George, M.; Basu, T.; Ramasubramanian, B.; Pradeepkiran, J.A.; et al. Defective mitophagy and synaptic degeneration in Alzheimer's disease: Focus on aging, mitochondria and synapse. Free Radic. Biol. Med. 2021, 172, 652-667. [CrossRef] [PubMed] · DOI
  49. Reddy, A.P.; Sawant, N.; Morton, H.; Kshirsagar, S.; Bunquin, L.E.; Yin, X.; Reddy, P.H. Selective serotonin reuptake inhibitor citalopram ameliorates cognitive decline and protects against amyloid beta-induced mitochondrial dynamics, biogenesis, autophagy, mitophagy and synaptic toxicities in a mouse model of Alzheimer's disease. Hum. Mol. Genet. 2021, 30, 789-810. [CrossRef] · DOI
  50. Vijayan, M.; Bose, C.; Reddy, P.H. Protective effects of a small molecule inhibitor, DDQ against amyloid beta in Alzheimer's disease. Mitochondrion 2021, 59, 17-29. [CrossRef] · DOI
  51. Vijayan, M.; Bose, C.; Reddy, P.H. Anti-brain Aging Effects of Small Molecule Inhibitor DDQ. Mol. Neurobiol. 2021, 58, 3588-3600. [CrossRef] · DOI
  52. Bailoo, J.D.; Bohlen, M.O.; Wahlsten, D. The precision of video and photocell tracking systems and the elimination of tracking errors with infrared backlighting. J. Neurosci. Methods 2010, 188, 45-52. [CrossRef] [PubMed] · DOI
  53. Gehring, T.V.; Luksys, G.; Sandi, C.; Vasilaki, E. Detailed classification of swimming paths in the Morris Water Maze: Multiple strategies within one trial. Sci. Rep. 2015, 5, 14562. [CrossRef] [PubMed] · DOI
  54. Deacon, R.M. Measuring motor coordination in mice. J. Vis. Exp. JoVE 2013, 75, e2609. [CrossRef] [PubMed] · DOI
  55. Singh, S.P.; Lee, J.; Bose, C.; Li, H.; Yuan, Y.-C.; Hindle, A.; Singhal, S.S.; Kopel, J.; Palade, P.T.; Jones, C.; et al. Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary Carcinogenesis. Cancers 2021, 13, 3329. [CrossRef] [PubMed] · DOI
  56. Esquerda-Canals, G.; Montoliu-Gaya, L.; Güell-Bosch, J.; Villegas, S. Mouse Models of Alzheimer's Disease. J. Alzheimers Dis. 2017, 57, 1171-1183. [CrossRef] [PubMed] · DOI · Paper page
  57. Kaech, S.; Banker, G. Culturing hippocampal neurons. Nat. Protoc. 2006, 1, 2406-2415. [CrossRef] [PubMed] · DOI
  58. Srivastava, S.K.; Ansari, N.H.; Hair, G.A.; Awasthi, S.; Das, B. Activation of human erythrocyte, brain, aorta, muscle, and ocular tissue aldose reductase. Metabolism 1986, 35, 114-118. [CrossRef] · DOI
  59. Singh, S.P.; Janecki, A.J.; Srivastava, S.K.; Awasthi, S.; Awasthi, Y.C.; Xia, S.J.; Zimniak, P. Membrane association of glutathione S-transferase mGSTA4-4, an enzyme that metabolizes lipid peroxidation products. J. Biol. Chem. 2002, 277, 4232-4239. [CrossRef] · DOI
  60. Engle, M.R.; Singh, S.P.; Czernik, P.J.; Gaddy, D.; Montague, D.C.; Ceci, J.D.; Yang, Y.; Awasthi, S.; Awasthi, Y.C.; Zimniak, P. Physiological role of mGSTA4-4, a glutathione S-transferase metabolizing 4-hydroxynonenal: Generation and analysis of mGsta4 null mouse. Toxicol. Appl. Pharm. 2004, 194, 296-308. [CrossRef] · DOI
  61. Alin, P.; Danielson, U.H.; Mannervik, B. 4-Hydroxyalk-2-enals are substrates for glutathione transferase. FEBS Lett. 1985, 179, 267-270. [CrossRef] · DOI
  62. Sharma, R.; Sharma, A.; Chaudhary, P.; Pearce, V.; Vatsyayan, R.; Singh, S.V.; Awasthi, S.; Awasthi, Y.C. Role of lipid peroxidation in cellular responses to D,L-sulforaphane, a promising cancer chemopreventive agent. Biochemistry 2010, 49, 3191-3202. [CrossRef] [PubMed] · DOI
  63. Zhou, Y.; Lin, N.; Zhang, B. An iteration normalization and test method for differential expression analysis of RNA-seq data. BioData Min. 2014, 7, 15. [CrossRef] [PubMed] · DOI
  64. Kramer, A.; Green, J.; Pollard, J., Jr.; Tugendreich, S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 2014, 30, 523-530. [CrossRef] [PubMed] · DOI · Paper page
  65. Singhal, J.; Singhal, S.S.; Yadav, S.; Suzuki, S.; Warnke, M.M.; Yacoub, A.; Dent, P.; Bae, S.; Sharma, R.; Awasthi, Y.C.; et al. RLIP76 in defense of radiation poisoning. Int. J. Radiat. Oncol. Biol. Phys. 2008, 72, 553-561. [CrossRef] · DOI
  66. Manczak, M.; Kandimalla, R.; Yin, X.; Reddy, P.H. Hippocampal mutant APP and amyloid beta-induced cognitive decline, dendritic spine loss, defective autophagy, mitophagy and mitochondrial abnormalities in a mouse model of Alzheimer's disease. Hum. Mol. Genet. 2018, 27, 1332-1342. [CrossRef] · DOI
  67. Kandimalla, R.; Manczak, M.; Yin, X.; Wang, R.; Reddy, P.H. Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer's disease. Hum. Mol. Genet. 2018, 27, 30-40. [CrossRef] · DOI
  68. Yadav, S.; Zajac, E.; Singhal, S.S.; Singhal, J.; Drake, K.; Awasthi, Y.C.; Awasthi, S. POB1 over-expression inhibits RLIP76-mediated transport of glutathione-conjugates, drugs and promotes apoptosis. Biochem. Biophys. Res. Commun. 2005, 328, 1003-1009. [CrossRef] · DOI
  69. Awasthi, Y.C.; Chaudhary, P.; Vatsyayan, R.; Sharma, A.; Awasthi, S.; Sharma, R. Physiological and pharmacological significance of glutathione-conjugate transport. J. Toxicol. Environ. Health B Crit. Rev. 2009, 12, 540-551. [CrossRef] · DOI
  70. Sharma, R.; Singhal, S.S.; Wickramarachchi, D.; Awasthi, Y.C.; Awasthi, S. RLIP76 (RALBP1)-mediated transport of leukotriene C4 (LTC4) in cancer cells: Implications in drug resistance. Int. J. Cancer 2004, 112, 934-942. [CrossRef] · DOI
  71. Awasthi, S.; Singhal, S.S.; Sharma, R.; Zimniak, P.; Awasthi, Y.C. Transport of glutathione conjugates and chemotherapeutic drugs by RLIP76 (RALBP1): A novel link between G-protein and tyrosine kinase signaling and drug resistance. Int. J. Cancer 2003, 106, 635-646. [CrossRef] [PubMed] · DOI · Paper page
  72. Watts, M.E.; Pocock, R.; Claudianos, C. Brain Energy and Oxygen Metabolism: Emerging Role in Normal Function and Disease. Front. Mol. Neurosci. 2018, 11, 216. [CrossRef] [PubMed] · DOI
  73. Reddy, A.P.; Yin, X.; Sawant, N.; Reddy, P.H. Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer's disease. Hum. Mol. Genet. 2021, 30, 847-864. [CrossRef] [PubMed] · DOI
  74. Kshirsagar, S.; Sawant, N.; Morton, H.; Reddy, A.P.; Reddy, P.H. Protective effects of mitophagy enhancers against amyloid beta-induced mitochondrial and synaptic toxicities in Alzheimer disease. Hum. Mol. Genet. 2021, 262. [CrossRef] [PubMed] · DOI
  75. Sakamoto, K.; Karelina, K.; Obrietan, K. CREB: A multifaceted regulator of neuronal plasticity and protection. J. Neurochem. 2011, 116, 1-9. [CrossRef] [PubMed] · DOI · Paper page
  76. Elfawy, H.A.; Das, B. Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: Etiologies and therapeutic strategies. Life Sci. 2019, 218, 165-184. [CrossRef] · DOI
  77. Saura, C.A.; Valero, J. The role of CREB signaling in Alzheimer's disease and other cognitive disorders. Rev. Neurosci. 2011, 22, 153-169. [CrossRef] · DOI · Paper page
  78. Wang, X.; Su, B.; Lee, H.G.; Li, X.; Perry, G.; Smith, M.A.; Zhu, X. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J. Neurosci. 2009, 29, 9090-9103. [CrossRef] · DOI · Paper page
  79. Wang, X.; Su, B.; Siedlak, S.L.; Moreira, P.I.; Fujioka, H.; Wang, Y.; Casadesus, G.; Zhu, X. Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc. Natl. Acad. Sci. USA 2008, 105, 19318-19323. [CrossRef] · DOI · Paper page
  80. Reddy, P.H.; Manczak, M.; Kandimalla, R. Mitochondria-targeted small molecule SS31: A potential candidate for the treatment of Alzheimer's disease. Hum. Mol. Genet. 2017, 26, 1483-1496. [CrossRef] · DOI
  81. Yin, X.; Manczak, M.; Reddy, P.H. Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease. Hum. Mol. Genet. 2016, 25, 1739-1753. [CrossRef] [PubMed] · DOI
  82. Reddy, P.H.; Manczak, M.; Yin, X.; Grady, M.C.; Mitchell, A.; Kandimalla, R.; Kuruva, C.S. Protective effects of a natural product, curcumin, against amyloid beta induced mitochondrial and synaptic toxicities in Alzheimer's disease. J. Investig. Med. 2016, 64, 1220-1234. [CrossRef] [PubMed] · DOI

Cited by

Sorted by citations

Authors
Awasthi, S., Hindle, A., Sawant, N. A., George, M., Vijayan, M., Kshirsagar, S., Morton, H., Bunquin, L. E., Palade, P. T., Lawrence, J. J., Khan, H., Bose, C., Reddy, P. H., & Singh, S. P.
Affiliations
  • Texas Tech University (US)
  • University of Arkansas for Medical Sciences (US)
Corresponding author
  • Reddy, P. Hemachandra
  • Singh, Sharda P.
Venue
Cells
Publisher
openRxiv
Published
2021-09-23
Volume
10
Issue
11
Pages
3113-3113
ISSN
2073-4409 (ISSN-L)
OpenAlex
W3213969099
Cited by
25
References
0
Citations by year
2026: 3 · 2025: 4 · 2024: 4 · 2023: 11 · 2022: 2 · 2021: 1
FWCI
2.75
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Cells (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • U.S. Department of Defense (W81XWH1810534, W81XWH-18-1-0534 SA, W81XWH, W81XWH-18)
  • National Institutes of Health (1r56ag066347-01a1, W81XWH, 1r56ag060767-01a1)
  • National Institute on Aging (R01AG042178, R01AG047812, R01AG069333)
  • National Institute of Neurological Disorders and Stroke (R01NS105473)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
RALBP1, RLIP76, Alzheimer's disease, oxidative stress, mitochondrial dysfunction, glutathione conjugate transport, cognitive decline, mitochondrial fission and fusion, synaptic integrity, CREB signaling, stress response, aging, gene network analysis
MeSH terms
Alzheimer Disease, Animals, Antioxidants, Behavior, Animal, Organelle Biogenesis, Disease Models, Animal, Gene Expression Regulation, Mitochondria, Models, Biological, RNA, Messenger, Synapses, Signal Transduction, Cyclic AMP Response Element-Binding Protein, Oxidative Stress, GTPase-Activating Proteins, Mice, Mitochondrial Dynamics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review